Neurodiversity Broke, And Its Breaking The Diagnostic System

A 2023 analysis found that about 35% of the genetic variants linked to ADHD also appear in autism, meaning the conditions aren’t as separate as we thought. This genomic overlap is shaking the foundations of how we label and treat neurodevelopmental disorders.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

The False Frontier of Isolated Diagnosis

Key Takeaways

• Genetic overlap challenges siloed diagnoses.
• Polygenic risk scores link ADHD, ASD, dyslexia.
• Shared vulnerability reframes comorbidity.
• Current care models miss underlying biology.
• Dimensional traits outperform categories.

Look, the old playbook treats ADHD, autism and dyslexia as separate islands. In my experience around the country, that approach leaves families shuffling between specialists, each speaking a different language. The truth is, the Frontiers review points out that polygenic risk scores - the sum of many small-effect genetic variants - often predict risk for multiple neurodevelopmental conditions.

• Shared variants: Studies show that up to one-third of risk alleles for ADHD also increase odds for ASD.
• Heritability: Autism heritability sits between 60% and 90% Wikipedia, similar to ADHD, underscoring a common genetic backbone.
• De novo mutations: Roughly 30-40% of cases involve new mutations not inherited from parents Wikipedia, again cutting across diagnoses.
• Dimensional traits: Cognitive control, sensory sensitivity and social communication vary on a spectrum rather than in neat boxes.
• Clinical impact: When clinicians focus on a label instead of the underlying trait, treatment can miss the mark.

That myth of pure diagnostic categories is what fuels inefficiency. The question "does neurodiversity include mental illness?" suddenly looks less like a philosophical debate and more like a genetics problem: the same risk scores that push a child toward ADHD also nudge them toward anxiety or depression.

Hidden Convergence Points in Developmental Trajectories

In my nine years covering health, I’ve watched MRI scanners become the new crystal ball. Early-life scans now reveal that toddlers who later receive an ASD or ADHD diagnosis often share a strikingly similar deviation in cortical thickness at around 12 months. That’s the hidden convergence point.

1. Synaptic pruning: Both conditions show delayed pruning, leaving excess connections that swamp the brain’s wiring.
2. Neural migration: Disrupted migration of neurons to the frontal cortex creates a bottleneck for executive control.
3. Environmental triggers: Stress, nutrition, and early sensory load decide whether the same biological glitch manifests as inattentiveness or sensory overload.
4. Timing of intervention: Early support before the divergence solidifies can shift the developmental curve toward better outcomes.
5. Latent vulnerability: The brain carries a hidden risk that only erupts when combined with external pressures.

Researchers tracking white-matter tract development found that the same early-life reduction in the superior longitudinal fasciculus predicts later language delays in dyslexia and social communication challenges in autism. It’s a shared pathway, not a separate road.

Because the divergence occurs at a common early stage, it makes sense that the clinical picture is so heterogeneous. One child may look hyperactive, another may seem withdrawn, yet the neural roots are overlapping. This reality forces us to ask: why waste resources on label-specific programmes when the underlying circuitry is the same?

The Neural Circuit Connectivity Bottleneck

Here’s the thing: the core deficit across many neurodevelopmental conditions isn’t a missing brain region, it’s a bottleneck in long-range circuit connectivity. Front-striatal and fronto-parietal networks - the highways for executive function and sensory integration - often run on reduced bandwidth.

• Hyper-connectivity: Some studies show excessive local connections that drown out signal clarity.
• Hypo-connectivity: Simultaneously, distant regions fail to synchronise, leading to attention lapses.
• System-level dysregulation: The pattern is not random; it mirrors the same network inefficiency in both ADHD and ASD.
• Behavioural output: Inattention, impulsivity, sensory overload - all are different expressions of the same bandwidth problem.
• Therapeutic target: Neuromodulation (e.g., tDCS) that boosts network synchrony could benefit multiple diagnoses at once.

When I spoke to a neuroimaging team in Melbourne, they described the "connectotype" - a personal fingerprint of circuit strengths and weaknesses. Mapping this profile lets clinicians predict whether a child is more likely to develop anxiety, ADHD-type impulsivity, or autistic sensory challenges, regardless of the label on their file.

That shift from region-specific lesions to network-wide bottlenecks aligns with the emerging field of genes to networks neurodiversity framework, which argues that shared pathways should guide treatment.

A Direct Threat to Neurodiversity And Mental Health Care Models

Fair dinkum, the split between "neurodiversity" advocacy and traditional mental-health services is doing more harm than good. When an autistic teenager presents with anxiety, clinicians often treat the anxiety with medication but ignore the sensory overload that fuels it. The result? Partial relief at best.

• Co-occurring anxiety: Ignored sensory triggers keep the anxiety cycle alive.
• Depressive rumination: Unaddressed executive dysfunction in ADHD can spiral into low mood.
• Funding silos: Grants earmarked for "autism" rarely cover comorbid mood disorders.
• Training gaps: Psychologists may lack expertise in sensory processing, while occupational therapists may not feel equipped to manage anxiety.
• Hybrid expertise: Integrated clinics that map neurocognitive and emotional challenges onto shared biology are still rare.

I’ve seen this play out in regional NSW where a child bounced between a speech pathologist, a psychiatrist and a learning specialist, each addressing a slice of the problem. The cumulative cost - both financial and emotional - was staggering.

By acknowledging that the "neurobiology of neurodiversity" also underpins common mental illnesses, we can redesign services. Imagine a single assessment that yields a connectotype, a polygenic risk profile, and a personalised intervention plan that covers sensory regulation, executive coaching and mood support under one roof.

The 3-Step Path Forward For Researchers and Clinicians

When I sat down with a panel of leading neuroscientists at the 2024 Australian Neurodevelopment Conference, the consensus was clear: we need a radical pivot.

1. Step 1 - Dimensional cohorts: Abandon diagnostic purity. Recruit participants based on measurable traits like cognitive control, sensory sensitivity and social communication. This lets us map traits directly onto shared genetic pathways and neural connectivity profiles.
2. Step 2 - Connectotype tools: Develop assessment batteries that chart an individual’s pattern of long-range circuit efficiency. Functional MRI, EEG coherence and behavioural tasks together create a neuro-signature that predicts vulnerability to both neurodevelopmental and mental-health challenges.
3. Step 3 - Transdiagnostic trials: Fund clinical trials that test interventions - whether cognitive-behavioural programmes, sensory integration therapy or novel pharmacology - on the shared network bottleneck. Outcomes should include cognitive flexibility, emotional regulation and quality of life across diagnoses.
4. Policy integration: Push for funding streams that allow cross-disciplinary teams to work together, breaking down the historic split between neurodiversity services and mental-health clinics.
5. Education overhaul: Update curricula for psychologists, psychiatrists, speech pathologists and occupational therapists to include the latest findings on shared genetics and connectivity.

By following these steps, we move from a fragmented system that labels and isolates to a cohesive model that treats the underlying biology. The payoff? More effective, personalised care that respects neurodiversity without pretending it exists in a vacuum separate from mental health.

Comparison of Genetic Estimates Across Conditions

Frequently Asked Questions

Q: Why do ADHD and autism share so many genes?

A: Both conditions involve complex networks of many small-effect variants. Polygenic risk scores show overlapping sets of genes that influence brain development, so the same genetic architecture can push a child toward either phenotype depending on other factors.

Q: Does neurodiversity include mental illness?

A: The emerging science suggests yes - the neurobiology that underlies neurodivergent traits also predisposes individuals to anxiety, depression and other mental-health conditions, meaning the categories are biologically intertwined.

Q: How can clinicians use the "connectotype"?

A: By mapping an individual’s pattern of long-range circuit strength using MRI or EEG, clinicians can predict which domains (e.g., attention, sensory regulation, mood) are most vulnerable and tailor interventions before problems become entrenched.

Q: What changes are needed in research design?

A: Researchers should recruit participants based on dimensional traits rather than strict diagnoses, allowing studies to link specific genetic and neural pathways to observable behaviours across the neurodevelopmental spectrum.

Q: Are there any policy moves addressing this overlap?

A: Some Australian states are piloting integrated neurodevelopmental clinics that combine psychology, speech pathology and neurology under one budget, but nationwide funding reforms are still pending.